phenylalanine has been researched along with Animal Mammary Carcinoma in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
CHEN, JT; HSU, B; WU, TC | 1 |
Elliott, BE; Hui, AY; Lin, EH; Meens, JA; Schaefer, E; Tremblay, EA | 1 |
Foekens, JA; Klijn, JG; Magdolen, V; Muehlenweg, B; Schmalix, WA; Schmitt, M; Setyono-Han, B; Sieuwerts, AM; Stürzebecher, J; Timmermans, M | 1 |
Bone, EA; Box, GM; Brown, PD; Court, WJ; Eccles, SA; Thomas, W | 1 |
Grinberg, S; James, PE; O'Hara, JA; Panz, T; Swartz, HM | 1 |
Chen, H; Feng, YM | 1 |
6 other study(ies) available for phenylalanine and Animal Mammary Carcinoma
Article | Year |
---|---|
[STUDIES ON ANTITUMOR DRUGS. XI. TOXICITY AND THERAPEUTIC EFFECTS OF P-BIS-(2-CHLOROETHYL)-AMINOMETHYL PHENYLALANINE (AT-290)].
Topics: Animals; Antineoplastic Agents; Blood Coagulation; Carcinoma, Ehrlich Tumor; Fibrosarcoma; Hematopoietic System; Leukocytes; Mammary Neoplasms, Animal; Mammary Neoplasms, Experimental; Mice; Nitrogen Mustard Compounds; Pharmacology; Phenylalanine; Rats; Research; Sarcoma; Sarcoma, Experimental | 1962 |
Disruption of Ca2+-dependent cell-matrix adhesion enhances c-Src kinase activity, but causes dissociation of the c-Src/FAK complex and dephosphorylation of tyrosine-577 of FAK in carcinoma cells.
Topics: Amino Acid Substitution; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Carcinoma; Cell Line, Tumor; Cell-Matrix Junctions; CSK Tyrosine-Protein Kinase; Enzyme Activation; Fibronectins; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Mammary Neoplasms, Animal; Mice; Phenylalanine; Phosphorylation; Protein-Tyrosine Kinases; Signal Transduction; src Homology Domains; src-Family Kinases; Tyrosine | 2004 |
Suppression of rat breast cancer metastasis and reduction of primary tumour growth by the small synthetic urokinase inhibitor WX-UK1.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Evaluation, Preclinical; Female; Gene Expression Regulation, Neoplastic; Mammary Neoplasms, Animal; Neoplasm Metastasis; Neoplasm Transplantation; Phenylalanine; Plasminogen Activator Inhibitor 1; Rats; Rats, Inbred BN; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; RNA, Neoplasm; Urokinase-Type Plasminogen Activator | 2005 |
Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94).
Topics: Animals; Antineoplastic Agents; Drug Screening Assays, Antitumor; Female; Gelatinases; Lung Neoplasms; Mammary Neoplasms, Animal; Matrix Metalloproteinase 2; Metalloendopeptidases; Neoplasm Metastasis; Phenylalanine; Rats; Specific Pathogen-Free Organisms; Survival Rate; Thiophenes | 1996 |
Impact of the antimetastatic drug Batimastat on tumor growth and PO2 measured by EPR oximetry in a murine mammary adenocarcinoma.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Electron Spin Resonance Spectroscopy; Female; Mammary Neoplasms, Animal; Metalloendopeptidases; Mice; Mice, Inbred C3H; Oximetry; Oxygen; Phenylalanine; Thiophenes | 1999 |
Contribution of the residue Glu9, Glu46, and Phe49 to the biological activity of insulin-like growth factor-1.
Topics: Amino Acid Sequence; Amino Acid Substitution; Animals; Cell Division; Cells, Cultured; Cloning, Molecular; Culture Media; Escherichia coli; Female; Glutamic Acid; Humans; Insulin; Insulin-Like Growth Factor I; Mammary Neoplasms, Animal; Mice; Molecular Sequence Data; Mutagenesis, Site-Directed; Phenylalanine; Recombinant Proteins; Tumor Cells, Cultured | 2001 |